| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8964508 | Clinical Oncology | 2018 | 9 Pages |
Abstract
The cost of CXB is not prohibitive according to the National Institute for Health and Care Excellence threshold for implementation of new technology and may even be cost saving within 5 years compared with standard surgical management, depending on the uptake of the technology and the number of referral centres.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C. Rao, A. Stewart, A.P. Martin, B. Collins, D.M. Pritchard, T. Athanasiou, A. Sun Myint,